BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10688036)

  • 1. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.
    Davies G; Jiang WG; Mason MD
    J Urol; 2000 Mar; 163(3):985-92. PubMed ID: 10688036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
    Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
    Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
    Davies G; Jiang WG; Mason MD
    Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
    Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
    Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
    Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells.
    Vermeulen SJ; Bruyneel EA; Bracke ME; De Bruyne GK; Vennekens KM; Vleminckx KL; Berx GJ; van Roy FM; Mareel MM
    Cancer Res; 1995 Oct; 55(20):4722-8. PubMed ID: 7553655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G; Watkins G; Mason MD; Jiang WG
    Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid molecular and morphological responses of prostate cell lines to cell-cell contact.
    Bazou D; Davies G; Jiang WG; Coakley T
    Cell Commun Adhes; 2006; 13(5-6):279-94. PubMed ID: 17162670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
    Tomita K; van Bokhoven A; Jansen CF; Bussemakers MJ; Schalken JA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):870-4. PubMed ID: 10673383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection.
    Luo J; Lubaroff DM; Hendrix MJ
    Cancer Res; 1999 Aug; 59(15):3552-6. PubMed ID: 10446959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
    Dalrymple S; Antony L; Xu Y; Uzgare AR; Arnold JT; Savaugeot J; Sokoll LJ; De Marzo AM; Isaacs JT
    Cancer Res; 2005 Oct; 65(20):9269-79. PubMed ID: 16230388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
    Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
    Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.